Tumor Board Discussion: Mesothelioma - Nowak and Mansfield

Tumor Board Discussion: Mesothelioma - Nowak and Mansfield

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board in mesothelioma, involving a case with a 68-year-old male, with 30 pack years smoking history who presents to the ER due to a worsening shortness of breath at rest and with exertion, unresectable mesothelioma with chest wall invasion and pleural effusion thickening with enlarged mediastinal lymph nodes and right chest wall invasion. Thoracentesis revealed a serosanguineous fluid (removed 1.1 l) with improvement of the respiratory symptoms. Cytology was negative for malignancy. Thoracoscopy is done to obtain pleural biopsies. Listen as guests Dr. Aaron Mansfield and Dr. Anna Nowak discuss the case and offer treatment options.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(399)

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilienc...

18 Aug 47min

LCC Advances in ALK+ Cancer in Cantonese

LCC Advances in ALK+ Cancer in Cantonese

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The...

14 Aug 46min

Treating Advanced Thymic Cancers

Treating Advanced Thymic Cancers

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined...

4 Aug 59min

FDA Approval: Zidesamtinib and ROS1 NSCLC

FDA Approval: Zidesamtinib and ROS1 NSCLC

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephe...

28 Jul 24min

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore ...

21 Jul 47min

IASLC - Your First Faculty Job

IASLC - Your First Faculty Job

Starting your first faculty position can be both exciting and overwhelming. In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Arthi Sridhar to discuss the transition ...

7 Jul 41min

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped ...

23 Jun 45min

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -...

12 Jun 39min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
jss
liberal-halvtime
rss-nysgjerrige-norge
forskningno
rss-paradigmepodden
sinnsyn
smart-forklart
rekommandert
fjellsportpodden
tomprat-med-gunnar-tjomlid
villmarksliv
dekodet-2
rss-inn-til-kjernen-med-sunniva-rose
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
vett-og-vitenskap-med-gaute-einevoll
rss-fuglehundfolk
tidlose-historier